Related Experiment Video
Updated: Aug 3, 2026

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
Published on: November 23, 2019
Dephosphorylation of MnDPDP and related compounds by acid and alkaline phosphatase
K G Toft1, A H Myrset, T Skotland
1Nycomed Imaging AS, Research and Development, P.O. Box 4220 Nydalen, N-0401, Oslo, Norway. kim.gunnar.toft@no.nycomed-amersham.com
Abstract:
The enzymatic dephosphorylation of the magnetic resonance imaging contrast agent Teslascan was studied in in vitro experiments with acid phosphatase (prostatic, from human semen) and alkaline phosphatase (from human placenta). The active component, MnDPDP (manganese (II)-N,N'-dipyridoxylethylenediamine-N,N'-diacetate-5,5'-bis(phosphate), was dephosphorylated by both enzymes to the monophosphate MnDPMP and the totally dephosphorylated compound MnPLED. The corresponding zinc compound, ZnDPDP (which is a result of in vivo metabolism), was also dephosphorylated by both enzymes to ZnDPMP and ZnPLED. In separate experiments, both enzymes dephosphorylated MnDPMP and ZnDPMP. With the same amount of enzyme units, alkaline phosphatase was almost four times more active than acid phosphatase in dephosphorylating MnDPDP and ZnDPDP with only minor differences whether the substrate contained Mn or Zn. A similar difference in enzymatic activity was seen with the monophosphates, MnDPMP and ZnDPMP. This, taken together with the approximately 50 times higher activity of alkaline phosphatase than acid phosphatase in serum shows that alkaline phosphatase is responsible for most of the dephosphorylation of MnDPDP and its metabolites in vivo.
Insights
Alkaline phosphatase is significantly more active than acid phosphatase in dephosphorylating the MRI contrast agent Teslascan (MnDPDP) and its metabolites. This indicates alkaline phosphatase plays a major role in the in vivo metabolism of Teslascan.
Area of Science:
- Biochemistry
- Pharmacology
- Medical Imaging
Background:
- Teslascan (MnDPDP) is a magnetic resonance imaging contrast agent.
- Understanding its metabolic pathways is crucial for clinical application.
- Enzymatic dephosphorylation is a key metabolic process.
Purpose of the Study:
- To investigate the in vitro enzymatic dephosphorylation of Teslascan (MnDPDP) and its zinc analog (ZnDPDP).
- To compare the activity of acid phosphatase and alkaline phosphatase in this process.
- To determine the primary enzyme responsible for Teslascan metabolism in vivo.
Main Methods:
- In vitro enzymatic assays using acid phosphatase (human prostatic) and alkaline phosphatase (human placental).
- Dephosphorylation of MnDPDP and ZnDPDP to monophosphate (MnDPMP, ZnDPMP) and fully dephosphorylated (MnPLED, ZnPLED) forms.
- Enzyme kinetic comparisons between acid and alkaline phosphatases.
Main Results:
- Both acid and alkaline phosphatases dephosphorylated MnDPDP and ZnDPDP to MnDPMP/ZnDPMP and MnPLED/ZnPLED.
- Alkaline phosphatase exhibited approximately four times higher activity than acid phosphatase for both MnDPDP and ZnDPDP.
- Similar activity differences were observed for the monophosphate metabolites.
Conclusions:
- Alkaline phosphatase is significantly more efficient in dephosphorylating Teslascan and its metabolites compared to acid phosphatase.
- Given the higher activity of alkaline phosphatase in serum, it is likely responsible for the majority of Teslascan dephosphorylation in vivo.
- These findings provide insight into the pharmacokinetic profile of Teslascan.
More Related Videos
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway

